Assessment of Vardenafil in Patients With Erectile Dysfunction in Asia
Status:
Completed
Trial end date:
2004-04-01
Target enrollment:
Participant gender:
Summary
To demonstrate the efficacy, safety and tolerability of 10 mg oral vardenafil (BAY 38-9456)
compared to placebo for a period of 12 weeks in men with erectile dysfunction (ED)